Erlotinib tablet 150 mg

Erlotinib is an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor primarily used in the treatment of certain types of cancer. This medication is particularly effective for:

1. Non-Small Cell Lung Cancer (NSCLC):
   • Indicated for patients with metastatic NSCLC whose tumors have specific EGFR mutations.
2. Pancreatic Cancer:
   • Used in combination with other therapies for advanced pancreatic cancer.

Key Features:

• Dosage: Each tablet contains 150 mg of Erlotinib as Erlotinib hydrochloride.
• Administration: Should be taken on an empty stomach for optimal absorption.
• Mechanism of Action: Erlotinib works by blocking the signals that promote cancer cell growth, thereby inhibiting tumor progression.

Important Considerations:

• Side Effects: Common side effects may include skin rash, diarrhea, and nausea. Regular monitoring by a healthcare provider is recommended.
• Contraindications: Not suitable for patients with certain pre-existing conditions or those taking specific medications that may interact adversely.